(Q36844148)

16 August 2017

1 reference

title

Future aspects of botulinum neurotoxins (English)

1 reference

16 August 2017

K R Aoki

1

1 reference

16 August 2017

publication date

8 June 2007

1 reference

Journal of Neural Transmission

16 August 2017

published in

1 reference

16 August 2017

volume

115

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

567-573

1 reference

A further survey of the action of Clostridium botulinum toxin upon different types of autonomic nerve fibre.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0758-9

Re-engineering the target specificity of Clostridial neurotoxins - a route to novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0758-9

Botulinum and tetanus neurotoxins: emerging tools for the study of membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0758-9

Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0758-9

Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0758-9

A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0758-9

Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.

21 January 2018

1 reference

12 December 2020

Effect of botulinum toxin A on facial wrinkle lines in Koreans

1 reference

12 December 2020

Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1

1 reference

12 December 2020

Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain

1 reference

12 December 2020

Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.

1 reference

12 December 2020

Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins

1 reference

12 December 2020

Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc

1 reference

12 December 2020

Development of resistance to botulinum toxin type A in patients with torticollis

1 reference

12 December 2020

Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles

1 reference

12 December 2020

Evidence for antinociceptive activity of botulinum toxin type A in pain management

1 reference

12 December 2020

Botulinum toxin types A, B and D inhibit catecholamine secretion from bovine adrenal medullary cells

1 reference

12 December 2020

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

1 reference

12 December 2020

Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study

1 reference

12 December 2020

SV2 is the protein receptor for botulinum neurotoxin A.

1 reference

12 December 2020

p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia

1 reference

12 December 2020

Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy

1 reference

12 December 2020

Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

1 reference

12 December 2020

Tetanus and botulinal neurotoxins. Tools to understand exocytosis in neurons

1 reference

12 December 2020

Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity

1 reference

12 December 2020

SNAP-25 and syntaxin, but not synaptobrevin 2, cooperate in the regulated release of nerve growth factor

1 reference

12 December 2020

Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.

1 reference

12 December 2020

A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice.

1 reference

12 December 2020

Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety

1 reference

12 December 2020

Long-term botulinum toxin efficacy, safety, and immunogenicity.

1 reference

12 December 2020

Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity

1 reference

12 December 2020

Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm

1 reference

12 December 2020

Double-blind study of botulinum toxin in spasmodic torticollis

1 reference

12 December 2020

A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia

1 reference

12 December 2020

Modulation of botulinum neurotoxin A catalytic domain stability by tyrosine phosphorylation

1 reference

12 December 2020

A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.

1 reference

12 December 2020

Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A.

1 reference

12 December 2020

Descending modulation of central neural plasticity in the formalin pain test

1 reference

12 December 2020

DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1

1 reference

12 December 2020

Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord

1 reference

12 December 2020

Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats

1 reference

12 December 2020

The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

1 reference

12 December 2020

Insights into a basis for incomplete inhibition by botulinum toxin A of Ca2+-evoked exocytosis from permeabilised chromaffin cells

1 reference

12 December 2020

Clinical impact of antibody formation to botulinum toxin A in children

1 reference

12 December 2020

Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.

1 reference

12 December 2020

Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin.

1 reference

12 December 2020

The rat paw formalin test: comparison of noxious agents

1 reference

12 December 2020

Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial

1 reference

12 December 2020

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

1 reference

12 December 2020

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

1 reference

12 December 2020

A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis

1 reference

12 December 2020

Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A.

1 reference

12 December 2020

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study

1 reference

12 December 2020

Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation

1 reference

12 December 2020

TRPV1: a therapeutic target for novel analgesic drugs?

1 reference

12 December 2020

The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization

1 reference

12 December 2020

10.1007/S00702-007-0758-9

Identifiers

DOI

1 reference

16 August 2017

1 reference